Ascendis Pharma
ASND
#1614
Rank
โ‚ฌ11.44 B
Marketcap
187,25ย โ‚ฌ
Share price
2.19%
Change (1 day)
61.59%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Ascendis Pharma CIK: 0001612042
The 20-F is a 10-K equivalent for non-US companies, as a foreight company Ascendis Pharma only files 20-F reports

Thumbnail Ascendis Pharma
 20-F Annual Report 2024

20-F Annual Report 2024

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report 2023

20-F Annual Report 2023

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report 2022

20-F Annual Report 2022

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report 2021

20-F Annual Report 2021

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report 2020

20-F Annual Report 2020

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report 2019

20-F Annual Report 2019

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report 2018

20-F Annual Report 2018

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report 2017

20-F Annual Report 2017

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report

20-F Annual Report 2017-03-22

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report

20-F Annual Report 2016-04-15

Language: English

View Annual Report (20-F)
Thumbnail Ascendis Pharma
 20-F Annual Report

20-F Annual Report 2015-03-26

Language: English

View Annual Report (20-F)